About Microbiotica
Microbiotica is a company based in Cambridge (United Kingdom) founded in 2016 by Gordon Dougan and Trevor Lawley. Microbiotica has raised $82.84 million across 3 funding rounds from investors including Tencent, IP Group and Flerie. The company has 42 employees as of December 31, 2020. Microbiotica offers products and services including MB097 and MB310. Microbiotica operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Biogen, Alnylam and ATAI, among others.
- Headquarter Cambridge, United Kingdom
- Employees 42 as on 31 Dec, 2020
- Founders Gordon Dougan, Trevor Lawley
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Microbiotica Limited
- Date of Incorporation 08 Jul, 2016
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$82.84 M (USD)
in 3 rounds
-
Latest Funding Round
$67 M (USD), Series B
Mar 07, 2022
-
Investors
Tencent
& 6 more
-
Employee Count
42
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Microbiotica
Microbiotica offers a comprehensive portfolio of products and services, including MB097 and MB310.
Co-therapy with KEYTRUDA for advanced melanoma treatment.
Therapy for ulcerative colitis to improve patient outcomes.
People of Microbiotica
Unlock access to complete
Unlock access to complete
Funding Insights of Microbiotica
Microbiotica has successfully raised a total of $82.84M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $67 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Microbiotica
Microbiotica has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, IP Group and Flerie.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Flerie is engaged in investing in biotech and pharmaceutical companies.
|
Locked | Locked | Locked | |
|
Venture capital co-investments are made in UK later-stage businesses.
|
Locked | Locked | Locked | |
|
Venture capital investments are made in life sciences and deep tech.
|
Locked | Locked | Locked |
Investor details for Microbiotica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Microbiotica
Investment portfolio details for Microbiotica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Microbiotica
Detailed financials for Microbiotica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microbiotica Comparisons
Peer comparison for Microbiotica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Microbiotica
Microbiotica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Biogen, Alnylam and ATAI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
Detailed competitors of Microbiotica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microbiotica
Complete news archive for Microbiotica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Microbiotica
Microbiotica was founded in 2016.
Microbiotica is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Microbiotica is a funded company, having raised a total of $82.84M across 3 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Microbiotica is 42.
Microbiotica was founded in 2016 and is headquartered in Cambridge, United Kingdom. Operations focus on the biotechnology sector, where gut bacteria associated with specific phenotypes are identified to support the development of live bacterial therapeutics and biomarkers. These efforts target inflammatory bowel disease, immuno-oncology, and gut epithelial barrier repair, with precision applied to phenotype linkages for therapeutic applications.
Microbiotica's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Microbiotica offers MB097 and MB310.
Microbiotica has 7 investors. Key investors include Tencent, IP Group, Flerie, British Patient Capital, and Cambridge Innovation Capital.
The valuation of Microbiotica is $37.34M as of May 2018.